ContactPrint • DisclaimerPrivacy PolicyTerms & Conditions

Recent Publications


  • Cappable-seq Service now available !

    In close cooperation with New England Biolabs, Inc. (NEB), VERTIS is now able to make the new Cappable-seq method available to its customers. The method was developed by Laurence Ettwiller and Ira Schildkraut from NEB (Ettwiller, L. et al. 2016. BMC Genomics. 17, 1 (2016), 199).

    It represents the current most sensitive and robust method for the precise identification of bacterial transcription start sites (TSSs).

vertis Biotechnologie AG
Lise-Meitner-Str. 30
D-85354 Freising

Fon +49-(0)8161-18516-11
Fax +49-(0)8161-18516-12

Contact FormHow to find us

Company Profile

Established in 2000, vertis Biotechnologie AG is a privately held company with its core competence in the field of functional genomics. It was founded as a spin-off of the Technische Universität München-Weihenstephan.

Our mission is to bring the most efficient state-of-the-art tools for analysis of the transcriptomes to the worldwide biotech community. The strength of our service is customer-oriented flexibility which is based on our innovative technology platform which we have developed in our 16-year history. It is subjected to a continuous process of further improvement and optimization and is examined in co-operations with research institutions as well as with pharmaceutical and biotech companies.

All our products and services come with excellent technical support, friendly customer service and fast delivery